机译:囊性纤维化患者肺部加剧后肺功能回收肺功能和IVACAFTOR处理的G551D - CFTR突变
Departments of Medicine and Pediatrics Medical University of South Carolina;
University of Queensland Level 7 Centre for Child Health Research;
Division of Respirology Keenan Research Centre of Li Ka Shing Knowledge Institute Department of;
Johnson &
Johnson Medical Devices;
Vertex Pharmaceuticals Incorporated;
Vertex Pharmaceuticals (Europe) Limited;
National Heart and Lung Institute Imperial College;
Department of Pediatrics University of Colorado School of Medicine;
Cystic fibrosis; Pulmonary exacerbations; Ivacaftor; Cystic fibrosis transmembrane conductance regulator; Pulmonary function;
机译:囊性纤维化患者肺部加剧后肺功能回收肺功能和IVACAFTOR处理的G551D - CFTR突变
机译:经IVACAFTOR处理的G551D突变对囊性纤维化患者肠内CFTR的活化检测
机译:G551D CFTR突变调节囊性纤维化患者血液白细胞活化的Ivacaftor治疗结果
机译:Ivacafacter诱导铜绿假单胞菌蛋白酶蛋白质组蛋白质组变化,CF患者G551D突变患者
机译:接受IVACafacor治疗的G551D突变患者的生活质量,感知疾病严重程度和依从性的调查
机译:CFTR增效剂依伐卡托对携带G551D突变的囊性纤维化患者气道微生物群的影响
机译:囊性纤维化患者肺部恶化后肺功能恢复及ivacaftor治疗G551D-CFTR突变